The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
acv auctions insider sales and institutional investments update
Insiders sold 455,911 shares of ACV Auctions stock valued at $7.48 million in the last three months, with insiders owning 8.50% of the company. Institutional investors hold 88.55% of the stock, with Wellington Management increasing its stake by 61.3% to 1.7 million shares. JPMorgan Chase & Co. cut its price target for ACV Auctions from $24 to $20, suggesting a potential upside of 37.19%. The stock currently has a "Moderate Buy" rating, with an average target price of $23.14, while trading at $14.58.
truist securities expands biotech research team with new analyst appointment
Truist Securities has enhanced its biotech equity research team with the addition of Danielle Brill, who brings extensive experience from her previous roles at Raymond James and other firms. Brill's insights will support the firm's institutional clients in navigating the evolving biotech landscape, alongside a growing team of experts in various sectors. The firm aims to leverage new technologies and high-touch service to deliver differentiated, data-driven content to its clients.
sportradar group receives price target upgrades from multiple analysts
XTX Topco Ltd has increased its holdings in Sportradar Group to 25,591 shares, valued at $444,000, after acquiring 1,414 shares last quarter. Sportradar, which provides sports data services globally, has received multiple price target upgrades from analysts, with an average target of $23.22 and a current rating of "Moderate Buy." The stock recently traded at $22.55, reflecting a market cap of $25.06 billion and a 52-week range between $9.17 and $23.00.
cadence design systems earnings outlook and analyst ratings update
Cadence Design Systems, Inc. is projected to achieve earnings of $5.41 per share this fiscal year, with analysts giving it a "Moderate Buy" rating and a consensus price target of $326.92. Recent reports show mixed ratings from various firms, with target prices ranging from $295 to $365. The company reported a quarterly EPS of $1.49, missing estimates, and has a market cap of $66.67 billion. Insiders have sold over 108,000 shares recently, indicating a significant decrease in their ownership.
cognizant technology solutions sees increased institutional investment and analyst price target upgrades
Concurrent Investment Advisors LLC has increased its stake in Cognizant Technology Solutions, now holding 6,688 shares valued at $514,000. The stock, primarily owned by institutional investors, has received mixed ratings from analysts, with a consensus "Hold" rating and a target price of $81.39. Recent price targets have been raised by UBS Group and other firms, reflecting a cautious optimism about the company's performance.
jpmorgan chase and other investors increase stakes in f5 stock
JPMorgan Chase & Co. increased its stake in F5 by 24.7%, owning 409,130 shares valued at $90 million, while New York State Common Retirement Fund raised its holdings by 14.3%. Barclays lifted its price target for F5 from $246 to $296, indicating a potential upside, as the company reported strong quarterly earnings with a 5.7% revenue increase year-over-year. F5's stock is primarily held by institutional investors, with 90.66% ownership.
insider sales and hedge fund activity impact evgo stock performance
Insiders have sold over 23 million shares of EVgo, totaling approximately $116 million, while hedge funds have increased their stakes, with State Street Corp growing its position by 25.3%. Analysts have mixed ratings on the stock, with a consensus target price of $6.22, despite a recent price target reduction by UBS Group to $5.00. EVgo reported a quarterly revenue increase of 92.3% year-over-year, but missed EPS estimates, reflecting ongoing challenges in the market.
sight sciences sees mixed analyst ratings and institutional investment activity
The Manufacturers Life Insurance Company and GSA Capital Partners LLP recently acquired stakes in Sight Sciences, with American Century Companies increasing its holdings by 31.1%. The company, specializing in ophthalmic medical devices, has faced mixed analyst ratings, with a consensus "Hold" and a lowered price target from UBS Group to $5.00. Despite a recent trading volume of 30,379 shares, the stock has struggled, reflecting a market cap of $149.22 million and a 12-month low of $2.67.
Boston Beer, known for its flagship Samuel Adams Boston Lager, has seen its stock price target reduced by UBS Group from $315 to $290, maintaining a "neutral" rating. Analysts generally hold a "Hold" rating on the stock, with a consensus price target of $310.82, while shares recently traded at $252.74, down 1.5%. Institutional investors own over 81% of the company, reflecting significant interest in its performance amidst fluctuating market conditions.
institutional investors increase stakes in intel amid mixed analyst ratings
Dunhill Financial LLC increased its Intel shares by 22.6%, now holding 2,380 shares valued at $56,000. Other firms, including MKT Advisors LLC and Beaton Management Co. Inc., also raised their stakes, contributing to institutional investors owning 64.53% of Intel. Despite a recent stock price increase, analysts maintain a "Hold" rating, with Barclays lowering its price target to $23.00. Intel reported a quarterly loss of $0.46 EPS, missing estimates, while revenue fell 6.3% year-over-year.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.